ENTRY       D00321                      Drug
NAME        Finasteride (JAN/USP/INN);
            Propecia (TN);
            Proscar (TN)
PRODUCT     PROPECIA (Organon LLC)
            PROSCAR (Organon LLC)
  GENERIC   FINASTERIDE (A-S Medication Solutions)
            FINASTERIDE (A-S Medication Solutions)
            FINASTERIDE (A-S Medication Solutions)
            FINASTERIDE (A-S Medication Solutions)
            FINASTERIDE (Accord Healthcare)
            FINASTERIDE (Accord Healthcare)
            FINASTERIDE (American Health Packaging)
            FINASTERIDE (Aphena Pharma Solutions - Tennessee)
            FINASTERIDE (Aphena Pharma Solutions - Tennessee)
            FINASTERIDE (Ascend Laboratories)
            FINASTERIDE (Ascend Laboratories)
            FINASTERIDE (Asclemed USA)
            FINASTERIDE (Asclemed USA)
            FINASTERIDE (Asclemed USA)
            FINASTERIDE (Aurobindo Pharma Limited)
            FINASTERIDE (Aurobindo Pharma Limited)
            FINASTERIDE (AvPAK)
            FINASTERIDE (Bryant Ranch Prepack)
            FINASTERIDE (Bryant Ranch Prepack)
            FINASTERIDE (Bryant Ranch Prepack)
            FINASTERIDE (Bryant Ranch Prepack)
            FINASTERIDE (Bryant Ranch Prepack)
            FINASTERIDE (Burel Pharmaceuticals)
            FINASTERIDE (Camber Pharmaceuticals)
            FINASTERIDE (Camber Pharmaceuticals)
            FINASTERIDE (Cardinal Health 107)
            FINASTERIDE (Cipla USA)
            FINASTERIDE (Direct_Rx)
            FINASTERIDE (Dr Reddys Laboratories)
            FINASTERIDE (Dr Reddys Laboratories)
            FINASTERIDE (Dr. Reddy's Laboratories Limited)
            FINASTERIDE (Dr. Reddy's Laboratories Limited)
            FINASTERIDE (Exelan Pharmaceuticals)
            FINASTERIDE (Legacy Pharmaceutical Packaging)
            FINASTERIDE (Major Pharmaceuticals)
            FINASTERIDE (NuCare Pharmaceuticals)
            FINASTERIDE (NuCare Pharmaceuticals)
            FINASTERIDE (NuCare Pharmaceuticals)
            FINASTERIDE (NuCare Pharmaceuticals)
            FINASTERIDE (NuCare Pharmaceuticals)
            FINASTERIDE (NuCare Pharmaceuticals)
            FINASTERIDE (NuCare Pharmaceuticals)
            FINASTERIDE (Preferred Pharmacetucals)
            FINASTERIDE (Preferred Pharmaceuticals)
            FINASTERIDE (Preferred Pharmaceuticals)
            FINASTERIDE (Proficient Rx LP)
            FINASTERIDE (Proficient Rx LP)
            FINASTERIDE (Proficient Rx LP)
            FINASTERIDE (Proficient Rx LP)
            FINASTERIDE (QUALLENT PHARMACEUTICALS HEALTH LLC)
            FINASTERIDE (REMEDYREPACK)
            FINASTERIDE (REMEDYREPACK)
            FINASTERIDE (REMEDYREPACK)
            FINASTERIDE (REMEDYREPACK)
            FINASTERIDE (REMEDYREPACK)
            FINASTERIDE (REMEDYREPACK)
            FINASTERIDE (REMEDYREPACK)
            FINASTERIDE (Rising Health)
            FINASTERIDE (Rising Health)
            FINASTERIDE (Sun Pharmaceutical Industries)
            FINASTERIDE (Sun Pharmaceutical Industries)
            FINASTERIDE (Teva Pharmaceuticals USA)
            FINASTERIDE (Thirty Madison)
            FINASTERIDE (Thirty Madison)
            FINASTERIDE (Zydus Lifesciences Limited)
            FINASTERIDE (Zydus Pharmaceuticals USA)
FORMULA     C23H36N2O2
EXACT_MASS  372.2777
MOL_WEIGHT  372.5441
CLASS       Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 2499
            ATC code: D11AX10 G04CB01
            Product: D00321<JP/US>
            Product (mixture): D12486<US>
EFFICACY    Antiandrogen, 5alpha-Reductase inhibitor
TARGET      SRD5A2 [HSA:6716] [KO:K12344]
  PATHWAY   hsa00140(6716)  Steroid hormone biosynthesis
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D11 OTHER DERMATOLOGICAL PREPARATIONS
               D11A OTHER DERMATOLOGICAL PREPARATIONS
                D11AX Other dermatologicals
                 D11AX10 Finasteride
                  D00321  Finasteride (JAN/USP/INN) &lt;JP/US&gt;
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G04 UROLOGICALS
               G04C DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
                G04CB Testosterone-5-alpha reductase inhibitors
                 G04CB01 Finasteride
                  D00321  Finasteride (JAN/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Dermatological Agents
              Dermatological Agents, Other
               Dermatological Agents, Miscellaneous
                Finasteride
                 D00321  Finasteride (JAN/USP/INN)
             Genitourinary Agents
              Benign Prostatic Hypertrophy Agents
               Finasteride
                D00321  Finasteride (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2499  Others
                 D00321  Finasteride (JAN/USP/INN)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D00321  Finasteride
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Dehydrogenases
                SRD5A2
                 D00321  Finasteride (JAN/USP/INN) &lt;JP/US&gt;
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D00321
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00321
DBLINKS     CAS: 98319-26-7
            PubChem: 7847387
            ChEBI: 5062
            PDB-CCD: FIT
            LigandBox: D00321
            NIKKAJI: J367.472J
ATOM        27
            1   C1y C    25.2062  -19.0694
            2   C1y C    24.0333  -19.7462
            3   C1z C    25.2236  -17.7159
            4   C1x C    27.5515  -19.0985
            5   C1y C    22.8607  -19.0518
            6   C1x C    24.0333  -21.1054
            7   C1y C    26.4022  -17.0506
            8   C1x C    24.0567  -17.0274
            9   C1a C    25.2469  -16.2980
            10  C1x C    27.5689  -17.7450
            11  C1z C    21.6763  -19.7345
            12  C1x C    22.8723  -17.6983
            13  C1x C    22.8490  -21.7765
            14  C5a C    26.3963  -15.6563
            15  C1y C    21.6706  -21.0938
            16  C2x C    20.4979  -19.0518
            17  C1a C    21.6822  -18.3576
            18  N1b N    25.2293  -14.9621
            19  O5a O    27.5865  -14.9912
            20  N1x N    20.4979  -21.7705
            21  C2x C    19.3252  -19.7345
            22  C1d C    24.0567  -14.1919
            23  C5x C    19.3252  -21.0938
            24  C1a C    22.9600  -13.5035
            25  C1a C    23.2924  -15.2304
            26  C1a C    24.8094  -13.0893
            27  O5x O    18.1409  -21.7705
BOND        30
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 1
            8     3   9 1 #Up
            9     4  10 1
            10    5  11 1
            11    5  12 1
            12    6  13 1
            13    7  14 1 #Up
            14   11  15 1
            15   11  16 1
            16   11  17 1 #Up
            17   14  18 1
            18   14  19 2
            19   15  20 1
            20   16  21 2
            21   18  22 1
            22   20  23 1
            23   22  24 1
            24   22  25 1
            25   22  26 1
            26   23  27 2
            27    7  10 1
            28    8  12 1
            29   13  15 1
            30   21  23 1
///
